Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare Licenses Genetic Testing Controls for CF

NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has licensed from Sacred Heart Medical Center & Children’s Hospital in Spokane, Wash., exclusive rights to controls for genetic testing including screening for cystic fibrosis and for diseases common among Ashkenazi Jews.
 
The Milford, Mass.-based firm announced the licensing deal concurrent with the launch of its new genetic testing controls business line. This business line initially includes controls for warfarin sensitivity testing and thrombophilia testing, which were developed internally by SeraCare.
 
“In the coming months, we will continue to make key additions to the genetic controls product portfolio as this business line plays an important role in the company’s near-term growth strategy and future profitability,” SeraCare President and CEO Susan Vogt said in a statement.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.